Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02731326 · ClinicalTrials.gov registry record · NA

iPhone Helping Evaluate Atrial Fibrillation Rhythm Through Technology

A NA study of Atrial Fibrillation and Atrial Flutter, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
264
Enrollment target
1
Study location

NCT02731326 is a NA study of Atrial Fibrillation and Atrial Flutter that has completed, run by Columbia University. The registered enrollment target is 264 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02731326, a NA study of Atrial Fibrillation and Atrial Flutter, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
264 participants
Enrollment target
1
Study location

Study Summary

Atrial fibrillation (AF), a condition where the top chambers of the heart beat irregularly, is a major health problem. The long-term goal of this project is to use a personal, mobile heart monitor to help patients better recognize recurrent AF and improve patients' ability to better manage their condition. A total of 300 patients with a history of AF will be included in the study, with 150 patients receiving an iPhone with the mobile monitoring device and educational text messaging and the remaining 150 patients continuing with their regular medical care. Each patient will be included in the intervention period for 6 months. The rate of recurrent AF and treatments meant to manage AF and other heart conditions will be determined for both groups. Patients in both groups will complete a series of questionnaires at the start and end of the 6 month study period to look at differences in quality of life and knowledge of AF.

Conditions Studied

Atrial Fibrillation Atrial Flutter

Interventions

  • DEVICE AliveCor
  • BEHAVIORAL Behavioral Altering Messaging

Study Locations (1)

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 264 participants
Start Date 2015-03
Est. Completion 2020-12-31
Phase NA

Sponsor

Columbia University

958 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02731326

The ClinicalTrials.gov registry entry for NCT02731326 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 264 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (91% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which AliveCor is the first listed.

NCT02731326 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02731326 about?

NCT02731326 is a clinical study titled "iPhone Helping Evaluate Atrial Fibrillation Rhythm Through Technology". Atrial fibrillation (AF), a condition where the top chambers of the heart beat irregularly, is a major health problem. The long-term goal of this project is to use a personal, mobile heart monitor to help patients better recognize recurrent AF and improve patients' ability to better manage their con...

What is the current status of trial NCT02731326?

This trial is currently completed. It is a NA study. The enrollment target is 264 participants. The study started on 2015-03. Estimated completion is 2020-12-31.

What conditions does trial NCT02731326 study?

This clinical trial studies the following conditions: Atrial Fibrillation, Atrial Flutter.

What interventions are being tested in trial NCT02731326?

The interventions under investigation include: AliveCor (DEVICE), Behavioral Altering Messaging (BEHAVIORAL).

Who is sponsoring clinical trial NCT02731326?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02731326 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Fibrillation

All registered trials for this condition

Atrial Flutter

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.